Ładuje się......
Programmed cell death-1 and programmed cell death ligand-1 antibodies-induced dysthyroidism
BACKGROUND: Monoclonal antibodies blocking the programmed cell death-1 (PD-1) or its ligand (PD-L1) are a group of immune checkpoints inhibitors (ICIs) with proven antitumor efficacy. However, their use is complicated by immune-related adverse events (irAEs), including endocrine adverse events (eAEs...
Zapisane w:
| Wydane w: | Endocr Connect |
|---|---|
| Główni autorzy: | , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Bioscientifica Ltd
2018
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5937198/ https://ncbi.nlm.nih.gov/pubmed/29739808 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-18-0079 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|